FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Shelf Life Evaluation for Bamlanivimab and Etesevimab

FDA and HHS says that the shelf-life of Eli Lillys bamlanivimab and etesevimab, for treating Covid-19, are being evaluated, and an update regarding a ...

Medical Devices

FDA Clears SonoScape Video Endoscopy Device

FDA clears a SonoScape 510(k) for its flagship video endoscopy system HD-550 for gastrointestinal diagnosis.

Federal Register

Info Collection on Quick Turnaround Surveys

Federal Register notice: FDA seeks comments on an information collection extension for Generic Clearance for Quick Turnaround Testing of Communication...

Federal Register

Guide on Bioavailability Studies for Drug Submissions

Federal Register notice: FDA makes available a final guidance entitled Bioavailability Studies Submitted in NDAs or INDs General Considerations.

Human Drugs

Adagio Pauses Covid Drug EUA Submission

Adagio Therapeutics pauses its EUA submission for adintrevimab, a Covid-19 treatment that is not effective against the BA.2 variant.

Biologics

FDA Extends Review of Regeneron Regen-Cov BLA

After submitting additional requested data, FDA extends by three months its review of a Regeneron Pharmaceuticals BLA for Regen-Cov (casirivimab and i...

Federal Register

Draft Guide on Celiac Disease Drugs

Federal Register notice: FDA makes available a draft guidance on developing drugs for treating Celiac Disease.

Medical Devices

EUA for Covid-19 Breathalyzer

FDA grants InspectIR an emergency use authorization for the first Covid-19 diagnostic test that detects Covid-19 chemical compounds in breath samples.

Federal Register

Guide on ANDA Waivers for pH Adjusters

Federal Register notice: FDA makes available a draft guidance entitled Considerations for Waiver Requests for pH Adjusters in Generic Drug Products In...

Federal Register

Guide on Animal Drug Compounding

Federal Register notice: FDA makes available a final guidance on Compounding Animal Drugs from Bulk Drug Substances.